Terms: = Head and neck cancer AND PR, PGR, progesterone receptor
1354 results:
1. FNA of Meningioma with Rhabdoid Features Presenting as a Lateral neck Mass.
Trabzonlu L; Martinez-Lage M; Deschler D; Paly JJ; Faquin WC
Head Neck Pathol; 2024 Apr; 18(1):32. PubMed ID: 38658429
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical efficacy of induction chemoimmunotherapy for locally advanced hypopharyngeal carcinoma: a prospective phase Ⅱ study].
Gong HL; Tian S; Ding H; Tao L; Wang L; Wang J; Wang T; Zhang M; Shi Y; Xu CZ; Wu CP; Wang SZ; Zhou L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):350-356. PubMed ID: 38599645
[No Abstract] [Full Text] [Related]
3. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
[TBL] [Abstract] [Full Text] [Related]
4. Classification and prediction of chemoradiotherapy response and survival from esophageal carcinoma histopathology images.
Chen Y; Gao R; Jing D; Shi L; Kuang F; Jing R
Spectrochim Acta A Mol Biomol Spectrosc; 2024 May; 312():124030. PubMed ID: 38368818
[TBL] [Abstract] [Full Text] [Related]
5. [A Case of Unresectable Advanced Lower Esophageal Adenocarcinoma That Achieved Pathological Complete Response after Conversion Surgery following Nivolumab plus SOX Therapy].
Yamamichi K; Kotsuka M; Yoshida T; Hishikawa H; Mukaide H; Tokuhara K; Inoue K; Sekimoto M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1765-1767. PubMed ID: 38303200
[TBL] [Abstract] [Full Text] [Related]
6. First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Piha-Paul SA; Xu B; Dumbrava EE; Fu S; Karp DD; Meric-Bernstam F; Hong DS; Rodon JA; Tsimberidou AM; Raghav K; Ajani JA; Conley AP; Mott F; Fan Y; Fan J; Peng P; Wang H; Ni S; Sun C; Qiang X; Levin WJ; Ngo B; Ru QC; Wu F; Javle MM
Oncologist; 2024 Apr; 29(4):e514-e525. PubMed ID: 38297981
[TBL] [Abstract] [Full Text] [Related]
7. Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test.
Huang Q; Liu Z; Yu Y; Rong Z; Wang P; Wang S; Wu H; Yan X; Cho WC; Mu T; Li J; Zhao J; Qiu M; Hou Y; Li X
Br J Cancer; 2024 Mar; 130(4):694-700. PubMed ID: 38177659
[TBL] [Abstract] [Full Text] [Related]
8. The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of head and neck.
Naito T; Noji R; Kugimoto T; Kuroshima T; Tomioka H; Fujiwara S; Suenaga M; Harada H; Kano Y
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138214
[No Abstract] [Full Text] [Related]
9. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
10. Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation.
Viswanathan K; Behrman DB; Lubin DJ
Cancer Cytopathol; 2024 Apr; 132(4):224-232. PubMed ID: 38062948
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Zheng J; Zhang H; Li S; Kang Z; Zheng F; Yao Q; Zhang X; Wu Z; Wang J; Fang W; Li J; Chen G; Chen Y; Chen M
BMC Cancer; 2023 Dec; 23(1):1193. PubMed ID: 38053017
[TBL] [Abstract] [Full Text] [Related]
12. cancer Associated PRDM9: Implications for Linking Genomic Instability and Meiotic Recombination.
Ladias P; Markopoulos GS; Kostoulas C; Bouba I; Markoula S; Georgiou I
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003713
[TBL] [Abstract] [Full Text] [Related]
13. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic cancer Cells.
Che PP; Gregori A; Bergonzini C; Ali M; Mantini G; Schmidt T; Finamore F; Rodrigues SMF; Frampton AE; McDonnell LA; Danen EH; Slotman BJ; Sminia P; Giovannetti E
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1328-1343. PubMed ID: 37914140
[TBL] [Abstract] [Full Text] [Related]
14. Real-world data of immunotherapy from China in recurrent or metastatic head and neck squamous cell carcinoma.
Zhang X; Wang P; Chai Y; Zhou X; Li P; Wang X
Am J Otolaryngol; 2024; 45(1):104065. PubMed ID: 37879241
[TBL] [Abstract] [Full Text] [Related]
15. cancer and Atrial Fibrillation Comorbidities Among 25 Million Citizens in Shanghai, China: Medical Insurance Database Study.
Chen M; Li C; Zhang J; Cui X; Tian W; Liao P; Wang Q; Sun J; Luo L; Wu H; Li YG
JMIR Public Health Surveill; 2023 Oct; 9():e40149. PubMed ID: 37847541
[TBL] [Abstract] [Full Text] [Related]
16. High PGAP3 expression is associated with lymph node metastasis and low CD8
Hao N; Li M; Wang J; Song Y; Zhao Y; Zhang L; Yang X; Chen L; Ma J; Jia Q; Sui F
Pathol Res Pract; 2023 Nov; 251():154890. PubMed ID: 37839361
[TBL] [Abstract] [Full Text] [Related]
17. [Significance of neoadjuvant immunotherapy combined with chemotherapy in the treatment of larynx preservation in locally advanced hypopharyngeal squamous cell carcinoma].
Wu J; Hu G; Li M; Wang Z; Ma W; Wang X; Zhu J; Pan M; Zeng Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 37(9):715-720;728. PubMed ID: 37830119
[No Abstract] [Full Text] [Related]
18. Noninvasive radiomic analysis of enhanced CT predicts CTLA4 expression and prognosis in head and neck squamous cell carcinoma.
Zhu Y; Wu M
Sci Rep; 2023 Oct; 13(1):16782. PubMed ID: 37798374
[TBL] [Abstract] [Full Text] [Related]
19. Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
Maekawa N; Konnai S; Hosoya K; Kim S; Kinoshita R; Deguchi T; Owaki R; Tachibana Y; Yokokawa M; Takeuchi H; Kagawa Y; Takagi S; Ohta H; Kato Y; Yamamoto S; Yamamoto K; Suzuki Y; Okagawa T; Murata S; Ohashi K
PLoS One; 2023; 18(10):e0291727. PubMed ID: 37792729
[TBL] [Abstract] [Full Text] [Related]
20. Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review.
Wang HH; Steffens EN; Kats-Ugurlu G; van Etten B; Burgerhof JGM; Hospers GAP; Plukker JTM
Ann Surg Oncol; 2024 Jan; 31(1):433-451. PubMed ID: 37777688
[TBL] [Abstract] [Full Text] [Related]
[Next]